Canada
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada
Hi, what are you looking for?
Mugglehead Investment Magazine
Canada
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program
Psychedelics
Influencing policies, cataloguing proof of efficacy and assisting veterans integration processes will be ideal outcomes from partnership
International
Organization to supply GMP product for second major clinical trial down under this month
Canada
Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT
Psychedelics
Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance
Canada
First novel psilocybin compound to commence clinical development marks 'tremendous milestone' for biotechnology company
Research
Market growth to be driven by growing population seeking the latest reliable testing equipment
Cannabis
Free online resource designated as 'The Green Pages' intended to serve cannabis industry through streamlined list of banking options
Canada
Application follows successful pre-clinical animal studies at the University of Arkansas
